Molecular Characterization of Escherichia coli Producing Extended-Spectrum ß-Lactamase and MCR-1 from Sick Pigs in a Greek Slaughterhouse
-
Published:2023-11-14
Issue:11
Volume:12
Page:1625
-
ISSN:2079-6382
-
Container-title:Antibiotics
-
language:en
-
Short-container-title:Antibiotics
Author:
Avgere Ermioni1, Zafeiridis Christos23ORCID, Procter Kassandra A.14, Beloukas Apostolos14ORCID, Giakkoupi Panagiota25
Affiliation:
1. Department of Biomedical Sciences, University of West Attica, 12243 Athens, Greece 2. Public Health Policy Department, University of West Attica, 11521 Athens, Greece 3. Ministry of Rural Development and Food of Greece (General Directorate of Veterinary Services), Seconded National Expert to the European Commission (Directorate General of Health and Food Safety-Unit G4, Official Controls-Northern Ireland Liaison Team), Belfast BT96DR, UK 4. National AIDS Reference Centre of Southern Greece, Department of Public Health Policy, University of West Attica, 11521 Athens, Greece 5. Laboratory for the Surveillance of Infectious Diseases-LSID, Department of Public Health Policy, University of West Attica, 11521 Athens, Greece
Abstract
The first prospective surveillance of ESBL and colistin-resistant Escherichia coli recovered from sick pigs from a slaughterhouse in Central Greece aimed to investigate the spread of relevant genetic elements. In February 2021, 25 E. coli isolates were subjected to antimicrobial susceptibility testing using disk diffusion and broth microdilution techniques. PCR screening was conducted to identify ESBLs and mcr genes. Additional assays, encompassing mating-out procedures, molecular typing utilizing Pulsed-Field Gel Electrophoresis, multilocus sequence typing analysis, and plasmid typing, were also conducted. A 40% prevalence of ESBLs and an 80% prevalence of MCR-1 were identified, with a co-occurrence rate of 32%. The predominant ESBL identified was CTX-M-3, followed by SHV-12. Resistance to colistin, chloramphenicol, cotrimoxazol, and ciprofloxacin was detected in twenty (80%), fifteen (60%), twelve (48%), and four (16%) isolates, respectively. All blaCTX-M-3 harboring plasmids were conjugative, belonging to the incompatibility group IncI1, and approximately 50 kb in size. Those carrying blaSHV-12 were also conjugative, classified into incompatibility group IncI2, and approximately 70 kb in size. The mcr-1 genes were predominantly located on conjugative plasmids associated with the IncX4 incompatibility group. Molecular typing of the ten concurrent ESBL and MCR-1 producers revealed seven multilocus sequence types. The heterogeneous population of E. coli isolates carrying resistant genes on constant plasmids implies that the dissemination of resistance genes is likely facilitated by horizontal plasmid transfer.
Funder
Special Account for Research Grants at the University of West Attica and the M.SC. program in Public Health-Department of Public Health Policy, University of West Attica
Subject
Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Pharmacology, Toxicology and Pharmaceutics,Biochemistry,Microbiology
Reference28 articles.
1. Antimicrobial Resistance Collaborators (2022). Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet, 399, 629–655. 2. McEwen, S.A., and Collignon, P.J. (2018). Antimicrobial Resistance: A One Health Perspective. Microbiol. Spectr., 6. 3. Poirel, L., Madec, J.Y., Lupo, A., Schink, A.K., Kieffer, N., Nordmann, P., and Schwarz, S. (2018). Antimicrobial Resistance in Escherichia coli. Microbiol. Spectr., 6. 4. WHO Advisory Group and Intergrated Surveillance of Antimicrobial Resistance (AGISA) (2016). Critically Important Antimicrobials for Human Medicine, WHO. [4th ed.]. 5. World Organization for Animal Health (OIE) (2015). OIE List of Antimicrobial Agents of Veterinary Importance, OIE.
|
|